Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.

PropertyValue
has major subject area list Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Epigenesis, Genetic; Neoplasm Recurrence, Local; Ovarian Neoplasms

Search Criteria
  • Epigenetic Processes